Literature DB >> 30212600

Lymph node metastases in splenic flexure colon cancer: Is subtotal colectomy warranted?

Gilles Manceau1, Arnaud Mori1, Armelle Bardier2, Jeremy Augustin2, Sylvie Breton1, Jean-Christophe Vaillant1, Mehdi Karoui1.   

Abstract

BACKGROUND AND OBJECTIVES: Tumors of the splenic flexure (TSF) can be associated with metastatic lymph nodes (LN) along the left colic pedicle, but also along the superior mesenteric vessels. We aimed to detail the anatomical distribution of metastatic LNs in patients undergoing elective subtotal colectomy for TSF.
METHOD: Between 2000 and 2016, 65 patients were included. At pathological analysis, LNs were classified into two groups: locoregional LN (along the left colic artery) and distant LN (along the middle colic, right colic, and ileocolic arteries).
RESULTS: The median number of LNs examined was 20. Eighteen patients (27%) were pN+. Among them, six (33% of pN+ patients and 9% of the series) had at least one positive distant LN. All these patients had a positive distant LN along the right colic artery. These patients had a significantly advanced stage and more positive LNs than the others (stage III-IV: 100% vs 22%, P = 0.0009 and 6 [3-15] vs 0 [0-15], P < 0.0001, respectively). The presence of synchronous metastases was predictor of metastatic distant LNs (P = 0.042).
CONCLUSION: Elective subtotal colectomy for TSF allows to discover distant positive LNs in nearly 10% of patients. For those having TSF and synchronous metastatic disease enable to resection, subtotal colectomy should be recommended.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  colorectal cancer; lymphatic spread; pathological examination; surgery

Mesh:

Year:  2018        PMID: 30212600     DOI: 10.1002/jso.25169

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  6 in total

1.  Extended right colectomy, left colectomy, or segmental left colectomy for splenic flexure carcinomas: a European multicenter propensity score matching analysis.

Authors:  Nicola de'Angelis; Aleix Martínez-Pérez; Des C Winter; Filippo Landi; Giulio Cesare Vitali; Bertrand Le Roy; Federico Coccolini; Francesco Brunetti; Valerio Celentano; Salomone Di Saverio; Frederic Ris; David Fuks; Eloy Espin
Journal:  Surg Endosc       Date:  2020-02-18       Impact factor: 4.584

2.  Elective surgery for tumours of the splenic flexure: a French inter-group (AFC, SFCD, FRENCH, GRECCAR) survey.

Authors:  G Manceau; S Benoist; Y Panis; A Rault; M Mathonnet; D Goere; J J Tuech; D Collet; C Penna; M Karoui
Journal:  Tech Coloproctol       Date:  2020-01-14       Impact factor: 3.781

3.  Surgical Treatment of SplenicFlexure Colon Cancer: Analysisof Short-Term and Long-Term Outcomes of Three DifferentSurgical Procedures.

Authors:  Mingjin Huang; Xiaojie Wang; Yu Shao; Shenghui Huang; Ying Huang; Pan Chi
Journal:  Front Oncol       Date:  2022-06-24       Impact factor: 5.738

4.  Subtotal colectomy, extended right hemicolectomy, left hemicolectomy, or splenic flexure colectomy for splenic flexure tumors: a network meta-analysis.

Authors:  Xiaojie Wang; Zhifang Zheng; Min Chen; Xingrong Lu; Shenghui Huang; Ying Huang; Pan Chi
Journal:  Int J Colorectal Dis       Date:  2020-09-25       Impact factor: 2.796

5.  Emergency surgery for splenic flexure cancer: results of the SFC Study Group database.

Authors:  Nicola de'Angelis; Eloy Espin; Frederic Ris; Filippo Landi; Bertrand Le Roy; Federico Coccolini; Valerio Celentano; Angela Gurrado; Denis Pezet; Giorgio Bianchi; Riccardo Memeo; Giulio C Vitali; Alejandro Solis; Christine Denet; Salomone Di Saverio; Gian Luigi de'Angelis; Miquel Kraft; Paula Gonzálvez-Guardiola; Aine Stakelum; Fausto Catena; David Fuks; Des C Winter; Mario Testini; Aleix Martínez-Pérez
Journal:  World J Emerg Surg       Date:  2021-04-29       Impact factor: 5.469

6.  Short- and long-term outcomes of laparoscopic segmental left colectomy for splenic flexure colon cancer: comparison with propensity score matching.

Authors:  Moon Jin Kim; Ji Hoon Kim; Yoon Suk Lee; Bong Hyeon Kye; Hyeon Min Cho; Hyung Jin Kim; Won Kyung Kang
Journal:  Ann Surg Treat Res       Date:  2021-10-29       Impact factor: 1.859

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.